TNX-102 SL 5.6 mg

· Tonix Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNX-102 SL 5.6 mg, covering 2018-04-24 to 2018-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules [Phase 1]